Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1997
08/12/1997US5656301 Mixed with additional medicinal agent selected from fibronectin, laminin, antiviral and antiinflammatory agents and carrier
08/12/1997US5656300 Topical compositions containing LYCD and minoxidil
08/12/1997US5656299 Sustained release microsphere preparation containing antipsychotic drug and production process thereof
08/12/1997US5656295 Controlled release oxycodone compositions
08/12/1997US5656294 Colonic delivery of drugs
08/12/1997US5656293 Delivery system for enhanced onset and increased potency
08/12/1997US5656291 Controlled release preparation
08/12/1997US5656290 Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
08/12/1997US5656288 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions
08/12/1997US5656264 Administering to the scalp of the male a preperation consiting of 6-benzylaminopurine
08/12/1997US5656261 Using a thiazolium compound
08/12/1997US5656256 Useful for treatment of cystic fibrosis and chronic bronchitis
08/12/1997US5656255 Composition to help stop smoking
08/12/1997US5655521 Facilitating oxygen delivery through lung by administering fluorocarbon liquid having positive equilibrium coefficient of spreading, introducing breathing gas which mixes with and oxygenates fluorocarbon within lung
08/12/1997CA1339275C New substituted cephalosporin sulfones as anti-inflammatory and antidegenerative agents
08/12/1997CA1339257C Nail lacquer with antimycotic activity, and a process for the preparat ion thereof
08/12/1997CA1339256C Treatment of diseases associated with hiv-infections
08/08/1997CA2196505A1 Use of phbm for the treatment of infections caused by intracellularly proliferating agents
08/07/1997WO1997028280A1 Diagnostic method and apparatus
08/07/1997WO1997028269A1 Transduced human hematopoietic stem cells
08/07/1997WO1997028266A1 Human dnase resistant to actin inhibition
08/07/1997WO1997028263A1 Recombinant expression of s-layer proteins
08/07/1997WO1997028259A1 Gene expression vectors which generate an antigen specific immune response and methods of using the same
08/07/1997WO1997028254A1 Antigenic modulation of cells
08/07/1997WO1997028251A1 Combined radiotherapy and immunotherapy to treat cancer
08/07/1997WO1997028190A1 Cytokine antagonists and agonists
08/07/1997WO1997028189A1 Methods for increasing endogenous levels of corticotropin-releasing factor
08/07/1997WO1997028184A1 Method of treating beta-amyloid peptide associated conditions using trh
08/07/1997WO1997028179A1 Method for inhibiting tumor cell growth
08/07/1997WO1997028178A1 High affinity nucleic acid ligands of complement system proteins
08/07/1997WO1997028169A1 Triazole derivatives useful in therapy
08/07/1997WO1997028168A1 Non-nucleotide phosphorous ester oligomers
08/07/1997WO1997028167A1 2-substituted amino and thio alkyl benzoxazine antimicrobial agents
08/07/1997WO1997028165A1 Derivatives of camptothecin for use in treating cancer
08/07/1997WO1997028164A1 9,10 disubstituted camptothecin derivatives with antitumor activity
08/07/1997WO1997028163A1 Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
08/07/1997WO1997028160A1 Endothelin receptor antagonists
08/07/1997WO1997028159A1 Endothelin receptor antagonists
08/07/1997WO1997028158A1 Endothelin receptor antagonists
08/07/1997WO1997028156A1 Taxane derivatives having a pyridyl substituted c13 side chain, their preparation and their use as anti-tumor agents
08/07/1997WO1997028155A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
08/07/1997WO1997028154A1 Endothelin receptor antagonists
08/07/1997WO1997028153A1 Chinoline and benzimidazole derivatives as bradykinin agonists
08/07/1997WO1997028149A1 Method for raising hdl cholesterol levels
08/07/1997WO1997028148A1 Dihydrobenzofuran compounds useful as anti-inflammatory agents
08/07/1997WO1997028147A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
08/07/1997WO1997028146A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
08/07/1997WO1997028145A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
08/07/1997WO1997028144A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
08/07/1997WO1997028143A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
08/07/1997WO1997028141A1 Novel aromatic piperazines derived from substituted cycloazanes, method for preparing same, pharmaceutical compositions, and use thereof as drugs
08/07/1997WO1997028140A1 NOVEL PIPERIDINES DERIVED FROM 1-/(PIPERAZIN-1-YL)ARYL(OXY/AMINO)CARBONYL/-4-ARYL-PIPERIDINE AS SELECTIVE 5-HT1Db RECEPTOR ANTAGONISTS
08/07/1997WO1997028137A1 Heterocyclic derivatives as antidiabetic and antiobesity agents
08/07/1997WO1997028135A1 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
08/07/1997WO1997028131A1 New phenanthridines
08/07/1997WO1997028130A1 Isoquinoline derivatives and drugs
08/07/1997WO1997028129A1 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents
08/07/1997WO1997028128A1 Heterocyclic compounds useful as pharmaceutical agents
08/07/1997WO1997028125A1 Dihydropyridine derivatives and medicinal compositions containing the same
08/07/1997WO1997028123A1 Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
08/07/1997WO1997028121A1 Alkylated styrenes as prodrugs to cox-2 inhibitors
08/07/1997WO1997028120A1 Diphenyl stilbenes as prodrugs to cox-2 inhibitors
08/07/1997WO1997028116A1 Biphenyl compounds and use thereof as oestrogenic agents
08/07/1997WO1997028115A1 Antidiabetic agents
08/07/1997WO1997027875A1 5α-REDUCTASE INHIBITORY PREPARATION FOR ORAL ADMINISTRATION, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF
08/07/1997WO1997027874A1 Use of angiogenic lipids for vascularizing tissue
08/07/1997WO1997027872A1 Immunomodulatory methods using oligosaccharides
08/07/1997WO1997027869A1 Method for treatment of benign prostatic hypertrophy
08/07/1997WO1997027867A1 Protection of hemopoietic cells
08/07/1997WO1997027866A1 Methods for retreatment of patients afflicted with hepatitis c using consensus interferon
08/07/1997WO1997027863A1 Combined pharmaceutical preparation containing lhrh-analogous substances and anti-estrogens for treating gynaecological disorders
08/07/1997WO1997027862A1 Supplementation of glucocorticoids
08/07/1997WO1997027858A1 Combination therapy method for treating cancer using edatrexate and a taxane derivative, e.g. paclitaxel
08/07/1997WO1997027857A1 Antidiabetic agents
08/07/1997WO1997027855A1 A method of making pharmaceutically active taxanes orally bioavailable
08/07/1997WO1997027854A1 Inhibitors of farnesyl-protein transferase
08/07/1997WO1997027853A1 Inhibitors of farnesyl-protein transferase
08/07/1997WO1997027852A1 Inhibitors of farnesyl-protein transferase
08/07/1997WO1997027851A1 L-homoserine and l-homoserine lactone as bacteriostatic agents for m. tuberculosis and m. bovis
08/07/1997WO1997027850A1 Compositions including amiodarone and betaxolol
08/07/1997WO1997027849A1 Remedies for herpesvirus infection caused by herpesvirus and preventives for recurrence of the infection both containing triterpene derivatives as the active ingredient
08/07/1997WO1997027848A1 SENSITIZATION OF HER2/neu OVER-EXPRESSING CANCER CELLS TO CHEMOTHERAPEUTIC DRUGS
08/07/1997WO1997027847A1 Method of treating diabetes and related disease states
08/07/1997WO1997027846A1 Biphenyl compounds and use thereof as oestrogenic agents
08/07/1997WO1997027845A1 Antiglucocorticoid drug
08/07/1997WO1997027844A1 Composition for transdermal delivery of drugs
08/07/1997WO1997027841A1 Use of compositions comprising stabilized biologically effective compounds
08/07/1997WO1997027764A1 Food and vitamin preparations containing the natural isomer of reduced folates
08/07/1997WO1997027752A1 Inhibitors of farnesyl-protein transferase
08/07/1997WO1997027750A1 Aqueous caffeine dosage forms
08/07/1997WO1997027749A1 NITROSATED AND NITROSYLATED α-ADRENERGIC RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS AND THEIR USES
08/07/1997WO1997027745A1 Method of diagnosis and treatment and related compositions and apparatus
08/07/1997WO1997021815A3 Antifungal proteins
08/07/1997WO1997021811A3 Novel tyrosine kinase receptors and ligands
08/07/1997WO1997017085A3 A method for inhibiting attachment of h. influenzae to human cells using phosphorylated recombinant human beta-casein
08/07/1997WO1997012985A3 Multi-functional hematopoietic receptor agonists
08/07/1997DE19703816A1 Additives for injection or infusion solutions, especially of contrast agents
08/07/1997DE19605024A1 Neue selektive Taxane, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung New selective taxanes, processes for their preparation and their pharmaceutical use
08/07/1997DE19604920A1 Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel New 2,3-benzodiazepine derivatives, their preparation and use as medicaments
08/07/1997DE19604919A1 Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel New 2,3-benzodiazepine derivatives, their preparation and use as medicaments